News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Burgess Michael F.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2022 |
4
| Burgess Michael F. (Head of Research & Development) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 15,674 shares
@ $0
Granted 48,852 options to buy
@ $59.46, valued at
$2.9M
|
|
| 06/14/2021 |
4
| Burgess Michael F. (Director) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 15,000 options to buy
@ $3.67, valued at
$55.1k
|
|
| 06/01/2021 |
4
| Burgess Michael F. (Head of Research & Development) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 27,500 shares
@ $0
Granted 225,000 options to buy
@ $81.68, valued at
$18.4M
|
|
| 05/10/2021 |
3
| Burgess Michael F. (Head of Research & Development) has filed a Form 3 on SpringWorks Therapeutics, Inc. |
| 06/08/2020 |
4
| Burgess Michael F. (Director) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.22, valued at
$33.3k
|
|
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|